Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...
Weekly case counts for the two respiratory illnesses have spiked in Erie County since Christmas, rising from a few dozen each in late December to 268 RSV cases and 321 flu cases the week ending Jan.
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...
Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t ...
While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...
Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.
The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...
UPMC saw an increase in RSV cases in its health system, including in Lancaster County, a spokesperson said Jan. 7, especially ...
We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...
It is a potentially fatal virus that can lead to hospitalisations and death in infants, but also in elderly and chronically ill adults. Two RSV vaccines were approved for use in Australia last ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback